Niogermox*Nail Polish 6.6ml,Niogermox*Smalto Unghie 6,6ml,POLICHEM Srl

ACTIVE ingredients: Ciclopirox. Excipients: Etilacetato, ethanol (96%), cetostearyl alcohol, hydroxypropyl methylcellulose, purified water. INDICATIONS: Mild to moderate onychomycosis caused by dermatophyte fungi and/or fungi sensitive to ciclopirox, without the participation of ungueal matrix and. CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to ciclopirox or to any of the excipients; pa zients under the age of 18 years, due to a lack of clinical data in this age group. DOSAGE: For external use on fingernails, toenails and areas of skin directly adjacent (perionichio, iponichio). Unless otherwise prescribed by the doctor, apply a thin layer of the medicine once a day over the entire clean and dry surface of the patient. Apply medicated nail polish to the entire nail plate, 5 mm nearby, and, if possible, under the free edge of the nail. The product dries in about 30 seconds. Do not wash and treat nails for at least six hours. It is therefore recommended to take an evening product before going to bed. Upon completion of the quest or period of time, they can return to normal hygiene. P er remove the medicine does not require solvents or abrasives (to ese mpio nail files), and it is enough to wash the nails with water. If the product was accidentally removed by normal washing, then repeat the application of the product. It is recommended to regularly trim the free edge of the nail and remove all mat erial onicolitico. Treatment should be continued without stopping until the nail and the affected area are regenerated and the life has healed. Typically, 6 months of treatment are required for fingernails and 9 to 12 months of treatment for toenails. A fungal control culture should be performed 4 weeks after the end of treatment to avoid any interference with the results due to residual active substance. Since this is a local treatment, dosage adaptation for specific population groups is not required. In the absence of a response to therapy with medication and/or in the presence of prolonged interest in one or more fingernails and toenails, it is necessary to evaluate the possibility of one additional oral therapy. STORAGE: In order to protect the product from light, store the bottle with a glass outside. Keep the bottle tightly closed to prevent the product from evaporating. Do not store in the refrigerator. At temperatures below -15 degrees, the nail enamel can gel; This may even cause slight flocculation or slight sedimentation, a condition easily reversible by returning the product to ambient temperature (25 degrees C) by rubbing the vial between your palms until the solution becomes clear again (about a minute). This will not affect the quality or effectiveness of the product. Allows the bottle to be kept tightly closed when not in use. The product’ infi is flammable. Keep away from heat sources and open flames. Precautions: in case of hypersensitivity, treatment should be stopped and proper therapy must be instituted. As with all local treatments for onychomycosis, in the case of larger nails (> 5 nails), in the case of more than two thirds of the nail, if it changes you, and in the case of predisposing factors such as diabetes and disorders of the immune system, it should be taken take into account the addition of ta in systemic therapy. In patients with a history of diabetes mellitus to insulin-dependent or diabetic neuropathy, carefully weigh the risk inherent in the procedure for removing part of the onicolitica and infection, both in the case of care by a healthcare professional and in the case of clearance from the patient. Avoid contact with oc or mucous membranes. Medicines for external use. Don’t a pple of nail polishes and other cosmetic products on your nails between tt. The product contains cetostearyl alcohol, a substance that may cause local skin reactions, such as allergic contact dermatitis. INTERACTIONS: There are no known interactions between ciclopirox and other drugs. Not the back door, other forms of interaction. SIDE EFFECTS: Side effect frequency categories are defined as follows: very common (>=1/10); total (>=1/100, =1/1.000, =1/10.000,